Malignant ependymoma is a fast-growing tumor that forms in the brain or spinal cord, developing from cells that line the fluid-filled spaces within the central nervous system. Understanding what this diagnosis means, how the disease may progress, and the ways it can affect everyday life helps patients and families navigate the difficult journey ahead with greater clarity and hope.

Prognosis and Survival Outlook

When someone receives a diagnosis of malignant ependymoma, one of the first questions that comes to mind is about survival and what the future holds. The outlook for people with this condition varies considerably depending on several important factors. These include the tumor’s exact location in the brain or spinal cord, how much of the tumor can be safely removed during surgery, the age of the patient, and the specific genetic characteristics of the tumor cells themselves.^[2]

Malignant ependymomas are classified as grade 3 tumors, which means they grow quickly and behave aggressively compared to lower-grade forms of the disease. These tumors are more likely to spread within the central nervous system through the cerebrospinal fluid, though they rarely move beyond the brain and spinal cord to other parts of the body.^[2] The aggressive nature of grade 3 ependymomas means they can be more challenging to treat and have a higher chance of returning even after treatment.^[3]

The most significant factor affecting long-term survival is whether surgeons can completely remove the tumor. When a gross total resection—meaning removal of all visible tumor tissue—is achieved, patients generally have better outcomes than when only part of the tumor can be safely taken out.^[18] Unfortunately, the location of some ependymomas near vital brain structures or along the spinal cord can make complete removal impossible without causing serious harm to the patient.^[1]

Recent advances in understanding the molecular and genetic features of ependymomas have revealed that tumors with similar appearances under the microscope can behave very differently depending on their genetic makeup. Scientists have identified distinct genetic subgroups of ependymomas that respond differently to treatment and have varying survival rates.^[10] For example, posterior fossa ependymomas are divided into two main groups—PF-A and PF-B—with PF-A tumors generally having a more challenging course.^[18]

It is important to understand that prognosis is not destiny. Medical statistics describe what happened to large groups of patients in the past, but every person’s journey is unique. Some patients with challenging tumors live many years beyond expectations, while others face earlier complications. Factors such as overall health before diagnosis, access to specialized care, response to treatment, and even aspects we don’t fully understand all play a role in individual outcomes.

Natural Progression Without Treatment

If a malignant ependymoma is left untreated, the tumor continues to grow within the confined space of the skull or spinal canal. Because these are fast-growing tumors, symptoms typically worsen over time as the mass expands and puts increasing pressure on surrounding brain tissue or spinal nerves.^[3]

In the brain, an untreated malignant ependymoma can block the normal flow of cerebrospinal fluid—the protective liquid that cushions the brain and spinal cord. When this fluid cannot circulate properly, it builds up in the spaces within the brain called ventricles, creating a condition known as hydrocephalus. This buildup increases pressure inside the skull, causing severe headaches, nausea, vomiting, and potentially life-threatening complications if not addressed.^[4]

As the tumor grows, it increasingly compresses vital brain structures. Depending on where the tumor is located, this can lead to progressive neurological problems. Patients may experience worsening seizures, increasing confusion, personality changes, or loss of coordination and balance. Vision problems can develop and become more severe. In children, developmental milestones may be delayed or lost as the tumor interferes with normal brain function.^[1]

For tumors in the spinal cord, untreated growth leads to progressive weakness in the limbs. Patients may find it increasingly difficult to walk, eventually losing the ability to move their legs or arms. Numbness and tingling sensations spread as the tumor damages more nerves. Control over bladder and bowel function can be lost, leading to incontinence. Back or neck pain, often severe, becomes a constant presence as the tumor expands within the spinal canal.^[2]

Malignant ependymomas have the ability to spread through cerebrospinal fluid to other locations in the central nervous system. Without treatment, tumor cells can travel to distant sites in the brain or along the spinal cord, creating new tumors that cause additional symptoms and complications.^[6] This pattern of spread, while staying within the central nervous system, makes the disease progressively more difficult to manage.

Possible Complications

Even with treatment, malignant ependymoma can lead to various complications that affect quality of life and require ongoing management. These complications can arise from the tumor itself, from the treatments used to fight it, or from both.

One of the most serious complications is tumor recurrence. Malignant ependymomas have a tendency to grow back after initial treatment, especially when complete surgical removal was not possible. These recurrences can happen at the original tumor site or at new locations in the brain or spinal cord where tumor cells have spread through cerebrospinal fluid.^[7] Each recurrence typically requires additional treatment, which becomes increasingly challenging as options become more limited.

Surgery to remove an ependymoma, while often necessary, carries risks of its own. Because these tumors grow near or within delicate brain and spinal cord tissue, surgical removal can sometimes damage nearby structures. This may result in new neurological problems such as weakness, numbness, difficulty speaking, or problems with coordination that persist after surgery.^[14] In some cases, patients develop infections following surgery, which can be particularly serious when they occur in the brain or spinal cord.^[19]

Radiation therapy, commonly used after surgery to destroy remaining tumor cells, can cause both immediate and delayed complications. In the short term, patients may experience fatigue, skin irritation, nausea, and worsening of existing symptoms. Long-term effects can include damage to normal brain or spinal cord tissue, hormonal problems if the pituitary gland receives radiation, cognitive changes, and an increased risk of developing new tumors many years later.^[14]

Hydrocephalus represents another potential complication. Even after tumor removal, the normal circulation of cerebrospinal fluid may not fully recover, requiring the placement of a shunt—a drainage tube that redirects excess fluid away from the brain. Shunts can malfunction or become infected, necessitating additional surgeries to repair or replace them.^[4]

Seizures can develop as a complication of the tumor or its treatment. Some patients who never had seizures before their diagnosis begin experiencing them after surgery or during recovery. These seizures may require long-term medication to control and can affect activities like driving, work, and independence.^[1]

Chronic pain is a complication that many patients with spinal ependymomas face. This pain can result from nerve damage caused by the tumor or surgery, and it may be difficult to manage with conventional pain medications. Some patients develop a type of pain called neuropathic pain, which feels like burning, tingling, or electric shocks and requires specialized treatment approaches.^[19]

Emotional and psychological complications should not be overlooked. Depression, anxiety, and post-traumatic stress are common among patients dealing with malignant ependymoma. The uncertainty about the future, the physical limitations imposed by the disease, and the stress of repeated treatments can take a significant toll on mental health.^[23]

Impact on Daily Life

Living with malignant ependymoma affects virtually every aspect of daily life. The physical symptoms, treatment side effects, and emotional burden of the diagnosis create challenges that extend far beyond medical appointments and hospital stays.

Physical limitations can be substantial and vary depending on the tumor’s location and the effects of treatment. People with brain tumors may struggle with balance and coordination, making simple tasks like walking, dressing, or preparing meals more difficult and potentially dangerous. Weakness in the limbs, especially common with spinal tumors, can make it hard or impossible to work at previous jobs, particularly those requiring physical labor or fine motor skills.^[20]

Fatigue is one of the most commonly reported problems among people with brain and spinal tumors. This is not ordinary tiredness that improves with rest. It is a profound exhaustion that affects the ability to concentrate, complete daily tasks, and participate in social activities. Some patients report sleeping twelve to fifteen hours per day, especially during chemotherapy treatment.^[25] This level of fatigue makes maintaining employment extremely difficult and can lead to financial stress when patients must reduce work hours or stop working entirely.

Cognitive changes represent another significant challenge for many patients. Problems with memory, concentration, and the ability to process information can make it difficult to manage medications, keep track of appointments, or handle complex tasks at work. Some people experience personality changes or mood swings that strain relationships with family and friends. Children with ependymoma may fall behind on developmental milestones or struggle academically, requiring special educational support.^[4]

Social relationships often become complicated. Friends and extended family may not understand what the patient is experiencing, leading to feelings of isolation. The patient may look healthy on the outside while dealing with invisible symptoms like pain, fatigue, or cognitive problems. Some people withdraw from social activities because they lack energy or feel self-conscious about physical changes such as hair loss from chemotherapy or scarring from surgery.^[23]

For patients with spinal ependymomas, loss of bladder and bowel control can be particularly distressing and socially isolating. Managing incontinence requires planning and can make people reluctant to leave home or participate in activities they once enjoyed. Sexual function may also be affected, putting strain on intimate relationships.^[2]

The emotional impact of living with a malignant tumor cannot be overstated. Fear about the future, worry about recurrence, and grief over lost abilities and independence are common. Many patients find it helpful to work with a therapist or counselor who specializes in helping people cope with serious illness. Support groups, whether in person or online, provide connection with others who truly understand what living with ependymoma is like.^[25]

Financial pressures add another layer of stress. Medical bills can be overwhelming even with insurance. Loss of income due to inability to work, combined with increased expenses for medications, medical equipment, and transportation to appointments, can create significant hardship. Patients may need to rely on family members for financial support or seek assistance from charitable organizations.^[23]

Despite these challenges, many people with ependymoma find ways to adapt and maintain quality of life. Physical therapy can help improve strength and mobility. Occupational therapy teaches techniques for accomplishing daily tasks more easily. Assistive devices and home modifications can increase independence. Pain management specialists can help develop strategies to control chronic pain. Learning to pace activities, accept help from others, and focus on what is still possible rather than what has been lost are important coping strategies.^[25]

Support for Family Members and Clinical Trial Information

Family members play a crucial role in supporting someone with malignant ependymoma, and understanding how to help can make a significant difference in the patient’s journey. One important way families can assist is by learning about clinical trials and helping their loved one access these potentially beneficial research studies.

Clinical trials are research studies that test new treatments or new combinations of existing treatments. For rare tumors like ependymoma, clinical trials offer several potential advantages. They may provide access to promising new therapies before they become widely available. They also ensure that patients receive careful monitoring and attention from specialized medical teams. Additionally, participating in research contributes to advancing medical knowledge that may help future patients, which many people find meaningful.^[7]

Currently, there are no ependymoma-specific targeted therapies approved for general use, making participation in clinical trials particularly important for accessing new treatment approaches. Research is actively investigating drugs that target specific molecular pathways in ependymoma cells. Some studies are exploring immunotherapy approaches that help the immune system recognize and attack tumor cells.^[18]

Families can help patients find appropriate clinical trials in several ways. Online databases allow searching for trials by disease type and location. The treating medical team can also provide information about trials they are aware of, and some specialized cancer centers have clinical trial coordinators who help match patients with suitable studies. Not every patient will be eligible for every trial, as studies have specific requirements regarding tumor characteristics, prior treatments, and overall health status.

Before enrolling in a clinical trial, it is important for both patients and families to understand what participation involves. Questions to ask include: What is the purpose of this trial? What treatments or procedures will be involved? What are the potential benefits and risks? How does the experimental treatment compare to standard treatment? Will there be additional costs? How often will appointments be required? Understanding these details helps families make informed decisions about whether trial participation is right for their situation.

Beyond helping with clinical trial decisions, families provide essential practical and emotional support. Loved ones can assist by taking notes during medical appointments, helping keep track of medications and side effects, providing transportation to treatments, and helping with daily tasks when the patient is fatigued or physically limited. Many patients report that having someone accompany them to appointments helps them remember important information and feel less overwhelmed.^[25]

Emotional support from family is equally important. Simply being present, listening without trying to fix everything, and validating the patient’s feelings can provide tremendous comfort. Family members should also remember to take care of their own physical and mental health, as caregiving can be exhausting and stressful. Seeking support from other caregivers, joining support groups, or working with a counselor can help family members cope with their own emotions and avoid burnout.^[23]

Communication within the family is vital. Honest conversations about fears, needs, and preferences help everyone feel heard and reduce misunderstandings. Patients should feel comfortable expressing what kind of support is helpful and what feels overwhelming. Family members can share their own concerns and needs as well, creating an environment where everyone’s well-being matters.

For families of children with ependymoma, additional considerations arise. Parents must balance protecting their child while providing age-appropriate information about the illness. Siblings may need extra attention and reassurance as family routines change. Schools need to be informed and involved in supporting the child’s educational needs during and after treatment.